HomeCompareMDRA vs PLD

MDRA vs PLD: Dividend Comparison 2026

MDRA yields 9732.36% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDRA wins by $42205343452570088.00M in total portfolio value
10 years
MDRA
MDRA
● Live price
9732.36%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42205343452570096.00M
Annual income
$41,369,169,924,735,210,000,000.00
Full MDRA calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — MDRA vs PLD

📍 MDRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDRAPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDRA + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDRA pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDRA
Annual income on $10K today (after 15% tax)
$827,250.61/yr
After 10yr DRIP, annual income (after tax)
$35,163,794,436,024,925,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, MDRA beats the other by $35,163,794,436,024,920,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDRA + PLD for your $10,000?

MDRA: 50%PLD: 50%
100% PLD50/50100% MDRA
Portfolio after 10yr
$21102671726285052.00M
Annual income
$20,684,584,962,367,610,000,000.00/yr
Blended yield
98.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

MDRA
No analyst data
Altman Z
-63.4
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDRA buys
0
PLD buys
0
No recent congressional trades found for MDRA or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDRAPLD
Forward yield9732.36%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$42205343452570096.00M$6.50M
Annual income after 10y$41,369,169,924,735,210,000,000.00$5,256,436.18
Total dividends collected$42149677066811080.00M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MDRA vs PLD ($10,000, DRIP)

YearMDRA PortfolioMDRA Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$983,936$973,236.01$11,255$555.24+$972.7KMDRA
2$90,548,321$89,495,509.90$13,062$1,018.59+$90.54MMDRA
3$7,794,055,630$7,697,168,926.38$15,903$1,926.67+$7794.04MMDRA
4$627,538,769,782$619,199,130,257.48$20,839$3,823.32+$627538.75MMDRA
5$47,264,782,575,230$46,593,316,091,563.77$30,464$8,166.08+$47264782.54MMDRA
6$3,330,294,655,792,460$3,279,721,338,436,963.00$52,054$19,457.30+$3330294655.74MMDRA
7$219,535,770,211,624,400$215,972,354,929,926,430.00$109,886$54,188.93+$219535770211.51MMDRA
8$13,540,581,545,048,480,000$13,305,678,270,922,040,000.00$304,030$186,451.18+$13540581545048.18MMDRA
9$781,470,586,761,576,300,000$766,982,164,508,374,600,000.00$1,166,125$840,813.32+$781470586761575.13MMDRA
10$42,205,343,452,570,094,000,000$41,369,169,924,735,210,000,000.00$6,504,190$5,256,436.18+$42205343452570088.00MMDRA

MDRA vs PLD: Complete Analysis 2026

MDRAStock

Medra Corporation engages in the acquisition, development, and commercial exploitation of hydrogen-based technologies. The company primarily concentrates on fuel cells, hydrogen-specific sensors, and hydrogen safety. It seeks out technologies, secures those technologies through licensing agreements with the patent holders, and converts the technologies into viable products that it then produces and sells. DCH manufactures and sells a line of hydrogen sensors that are both mobile (a hand held unit) and stationary (wall ceiling or conduit mounted units) to a range of industries and customers. The company also develops, manufactures, and sells fuel cells that range from 12 watts to five kilo watts. Its H2SCAN hydrogen-specific sensing systems offer an alternative to gas detectors used in various industries, including food processing, petrochemical production, semiconductor manufacturing, and glass and metals processing. The company has licenses to various technologies, including The Robust Hydrogen Sensor, The Thick Film Hydrogen Sensor, and The Proton Exchange Membrane Fuel Cell. Medra Corporation was founded in 1994 and is based in Valencia, California.

Full MDRA Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this MDRA vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDRA vs SCHDMDRA vs JEPIMDRA vs OMDRA vs KOMDRA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.